2m 2m 2m 2m 2m 2m 2m
PROFOUND MEDICL (PROF)
NASDAQ
$6.53+$0.04 (+0.69%)
Price as of Jun 03, 2026 4:10 PM EDT- $247.5MMarket Cap
- 18.25%1-Year Change
- Medical DevicesIndustry
PROFOUND MEDICL (PROF)
$6.53+$0.04 (+0.69%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 9.7M -8.90% | 10.7M +48.35% | 7.2M +7.75% | 6.7M -2.79% | |
Cost of Revenue | 4.7M +29.15% | 3.6M +29.32% | 2.8M -23.03% | 3.7M -6.66% | |
Gross Profit | 11.4M +61.90% | 7.0M +60.59% | 4.4M +45.05% | 3.0M +2.34% | |
Sales and Marketing Expense | 32.1M +38.54% | 23.1M +144.73% | 9.5M +11.63% | 8.5M +10.66% | |
Research and Development Expense | -20.6M +21.40% | -17.0M +18.00% | -14.4M -2.13% | -14.7M -3.84% | |
Depreciation and Amortization Expense | 187,000 -18.34% | 229,000 N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 52.6M +31.29% | 40.1M +337.38% | 9.2M -3.14% | 9.5M -8.23% | |
Operating Profit | -41.3M +24.78% | -33.1M +15.54% | -28.6M -10.93% | -32.1M +6.06% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -394,000 N/A | N/A N/A | -146,000 -49.66% | -290,000 -35.27% | |
Interest Income and Expense and Net | -394,000 N/A | 0 +100.00% | -146,000 -49.66% | -290,000 -35.27% | |
Total Nonoperating Income and Expense | -1.1M -120.29% | 5.2M +3,491.78% | 146,000 -49.66% | 290,000 -35.27% | |
Income before Taxes | -42.3M +52.12% | -27.8M -2.63% | -28.6M -0.35% | -28.7M -6.61% | |
Income Taxes | 252,000 +12,700.00% | -2,000 -98.44% | -128,000 -144.60% | 287,000 +173.33% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -42.6M +53.04% | -27.8M -2.64% | -28.6M -0.35% | -28.7M -6.61% | |
Net Income from Continuing Operations Applicable to Common | -42.3M +52.12% | -27.8M -2.63% | -28.6M -0.35% | -28.7M -6.61% | |
Basic EPS and Net Income | 1.41 +25.89% | 1.12 -17.04% | 1.35 -2.17% | 1.38 -8.00% | |
Diluted EPS and Net Income | 1.41 +25.89% | 1.12 -17.04% | 1.35 -2.17% | 1.38 -8.00% | |
Basic Weighted Average Shares | 30.2M +22.08% | 24.8M +16.91% | 21.2M +1.69% | 20.8M +1.79% | |
Diluted Weighted Average Shares | 30.2M +22.08% | 24.8M +16.91% | 21.2M +1.69% | 20.8M +1.79% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 59.7M +8.76% | 54.9M +109.48% | 26.2M -43.65% | 46.5M -30.73% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 59.7M +8.76% | 54.9M +109.48% | 26.2M -43.65% | 46.5M -30.73% | |
Total Current Assets | 76.1M +10.17% | 69.1M +64.85% | 41.9M -32.45% | 62.0M -19.58% | |
Accumulated Depreciation | 1.6M -33.43% | 2.4M N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 698,000 +64.24% | 425,000 -53.25% | 909,000 +1.11% | 899,000 +14.09% | |
Total Long-Term Assets | 698,000 +64.24% | 425,000 N/A | N/A N/A | N/A N/A | |
Total Assets | 77.5M +10.31% | 70.2M +59.95% | 43.9M -31.84% | 64.4M -25.76% | |
Income Taxes Payable | 39,000 -33.90% | 59,000 -80.20% | 298,000 0.00% | 298,000 +2,192.31% | |
Total Short-Term Debt | 1.7M 0.00% | 1.7M N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 6.1M -7.46% | 6.6M +3.13% | 6.4M +52.11% | 4.2M +0.72% | |
Total Long-Term Debt | 4.5M +53.86% | 2.9M N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 79,000 +11.27% | 71,000 N/A | N/A N/A | N/A N/A | |
Total Liabilities | 11.0M +12.53% | 9.8M -22.93% | 12.7M +2.53% | 12.4M +101.67% | |
Retained Earnings | -287.7M +17.36% | -245.2M +12.50% | -217.9M +15.09% | -189.4M +17.84% | |
Total Stockholders Equity | 66.4M +9.95% | 60.4M +93.78% | 31.2M -40.04% | 52.0M -35.49% | |
Total Shares Outstanding | 36.3M +20.82% | 30.0M +40.57% | 21.4M +2.35% | 20.9M +0.50% | |
Cash Flow | |||||
Cash from Operating Activities | -38.2M +62.91% | -23.5M +5.18% | -22.3M -13.58% | -25.8M +15.38% | |
Capital Expenditures | 176,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -242,000 N/A | N/A N/A | N/A N/A | -593,000 0.00% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 41.1M -24.79% | 54.7M +3,636.07% | 1.5M -79.18% | 7.0M +18.21% | |
Financials Ratio | |||||
Gross Margin | 51.64% -21.62% | 65.89% +8.25% | 60.87% +34.61% | 45.22% +5.28% | |
Operating Margin | -423.99% +36.96% | -309.57% -22.12% | -397.50% -17.34% | -480.86% +9.11% | |
Return on Assets | -57.64% +18.27% | -48.74% -7.59% | -52.74% +39.08% | -37.92% +18.20% | |
Return on Equity | -67.12% +10.51% | -60.73% -11.58% | -68.69% +58.88% | -43.23% +25.32% | |
Revenue Growth | -8.90% -118.40% | 48.35% +523.66% | 7.75% +377.55% | -2.79% -52.66% | |
Current Ratio | 12.52 +19.06% | 10.52 +59.85% | 6.58 -55.59% | 14.82 -20.16% | |
Cash Ratio | 9.83 +17.53% | 8.36 +103.13% | 4.12 -62.95% | 11.12 -31.23% | |
Debt-to-Equity Ratio | 0.09 +21.79% | 0.08 N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.08 +21.23% | 0.07 N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow